Good point Karl. It does swing on a dime, with small volume.
At least they have the $80 million dollar bond facility and farm in arrangements where exploration costs are shared with the partners (or paid by them).
Personally I am sure no one likes the share price but then the market isn't great in general. The wire logging will move the price (either way - lol).
"total coal intersected maybe greater than detailed"
If the results were the same - they wouldn't have said this, if the results were not as good - they wouldn't have said this, if the results were possibly greater - why would you say it and then face disappointment? My personal opinion (IMHO), is that is the best they could say without breaking announcement rules.
Thoughts? Happy to have people disagree. That's my .14c worth.
- Forums
- ASX - By Stock
- CTP
- new announcement
new announcement, page-25
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
SKS
SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
Add CTP (ASX) to my watchlist
|
|||||
Last
4.8¢ |
Change
-0.004(7.69%) |
Mkt cap ! $35.52M |
Open | High | Low | Value | Volume |
5.0¢ | 5.0¢ | 4.8¢ | $22.36K | 454.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 104163 | 4.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.2¢ | 96150 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 104163 | 0.049 |
3 | 1201484 | 0.048 |
1 | 100000 | 0.046 |
2 | 280000 | 0.045 |
2 | 28222 | 0.041 |
Price($) | Vol. | No. |
---|---|---|
0.052 | 96150 | 1 |
0.055 | 11000 | 1 |
0.057 | 45000 | 1 |
0.059 | 25000 | 1 |
0.060 | 210909 | 3 |
Last trade - 11.34am 12/07/2024 (20 minute delay) ? |
Featured News
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
CTP (ASX) Chart |